Literature DB >> 16630215

Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism.

Z J Jun1, T Ping, Y Lei, L Li, S Y Ming, W Jing.   

Abstract

Venous thromboembolism (VTE) is a common vascular disease that results in two major clinical manifestations: deep venous thrombosis (DVT) and pulmonary embolism (PE). Several genetic risk factors, especially factor V Leiden and prothrombin G20210A mutations have been reported to be related to VTE in Caucasians, but the relationship remains controversial in other populations. Thus, the objective of the present study was to compare the frequency of the two mutations and also to investigate whether acquired risk factors other than genetic mutations may play a different role in Chinese VTE patients. Thirty-five patients were diagnosed with DVT concomitant PE, 178 patients with DVT, 54 patients with PE and 102 control subjects were recruited. The mutation was determined by the polymerase chain reaction-restriction fragment length polymorphism method. Of all subjects, none was a carrier of factor V Leiden or prothrombin G20210A mutations. The frequency of surgery was significantly higher in the PE group than that in other groups. There was no significant difference among the three groups in other known risk factors. The data presented here indicate that factor V Leiden and prothrombin G20210A mutations are very rare in the Chinese population, and the genetic risk profile of VTE in the Chinese population is different from that in Caucasians.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16630215     DOI: 10.1111/j.1365-2257.2006.00757.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  20 in total

1.  Incidence and risk of venous thromboembolism in patients following appendectomy: a nationwide cohort study.

Authors:  Wei-Sheng Chung; YuPei Chen; Weishan Chen; Cheng-Li Lin
Journal:  J Thromb Thrombolysis       Date:  2019-10       Impact factor: 2.300

2.  Risk-factor profile, drug usage and cardiovascular events within a year in patients with and at high risk of atherothrombosis recruited from Asia as compared with those recruited from non-Asian regions: a substudy of the REduction of Atherothrombosis for Continued Health (REACH) registry.

Authors:  S Goto; Y Ikeda; J C N Chan; P W F Wilson; T Cheng Yeo; C S Liau; M T Abola; G Salette; P G Steg; D L Bhatt
Journal:  Heart Asia       Date:  2011-01-01

Review 3.  Epidemiology and risk factors for venous thrombosis.

Authors:  Mary Cushman
Journal:  Semin Hematol       Date:  2007-04       Impact factor: 3.851

4.  Prevalence of factor V Leiden in south Tunisian blood donors.

Authors:  Lobna Maalej; Basma Hadjkacem; Ikram Ben Amor; Mariem Smaoui; Ali Gargouri; Jalel Gargouri
Journal:  J Thromb Thrombolysis       Date:  2011-07       Impact factor: 2.300

5.  The Prevalence of the Prothrombin (F2) 20210G>A Mutation in a Cohort of Sri Lankan Patients with Thromboembolic Disorders.

Authors:  K M D Gunathilake; U N D Sirisena; P K D Nisansala; H W W Goonasekera; R W Jayasekara; V H W Dissanayake
Journal:  Indian J Hematol Blood Transfus       Date:  2014-09-02       Impact factor: 0.900

6.  Genetic background of nontraumatic osteonecrosis of the femoral head in the Korean population.

Authors:  Jun-Dong Chang; Mina Hur; Sang-Soo Lee; Je-Hyun Yoo; Kyu Man Lee
Journal:  Clin Orthop Relat Res       Date:  2008-03-19       Impact factor: 4.176

Review 7.  The role of ethnicity, age and gender in venous thromboembolism.

Authors:  Martina Montagnana; Emmanuel J Favaloro; Massimo Franchini; Gian Cesare Guidi; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

8.  Risk factors of venous thromboembolism in thai patients.

Authors:  Pantep Angchaisuksiri; Vichai Atichartakarn; Katcharin Aryurachai; Napaporn Archararit; Buppa Rachakom; Kanlayanee Atamasirikul; Arjit Tiraganjana
Journal:  Int J Hematol       Date:  2007-12       Impact factor: 2.490

9.  Prevalence of positive factor V Leiden and prothrombin mutations in samples tested for thrombophilia in Saudi Arabia.

Authors:  Fatimah Madkhaly; Abdulaziz Alshaikh; Hala Aba Alkhail; Randa Alnounou; Tarek Owaidah
Journal:  Am J Blood Res       Date:  2021-06-15

10.  Meta-analysis of Factor V Leiden G1691A polymorphism and osteonecrosis of femoral head susceptibility.

Authors:  Xifu Shang; Zhengliang Luo; Xu Li; Fei Hu; Qichun Zhao; Wenzhi Zhang
Journal:  Biomed Rep       Date:  2013-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.